Evidence map›Paper›PMID 34462320›Full record

ArticleLife science alliance2021

High levels of TFAM repress mammalian mitochondrial DNA transcription in vivo.

Nina A Bonekamp, Min Jiang, Elisa Motori, Rodolfo Garcia Villegas, Camilla Koolmeister, Ilian Atanassov, Andrea Mesaros, Chan Bae Park, Nils-Göran Larsson

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Cooperative Architecture of Mitochondrial Proteome Homeostasis.medRxiv : the preprint server for health sciences · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Nina A BonekampDepartment of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, Germany nina.bonekamp@medma.uni-heidelberg.de.ORCID 0000-0001-9748-8089
Min JiangDepartment of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, Germany.ORCID 0000-0002-7005-937X
Elisa MotoriDepartment of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, Germany.ORCID 0000-0001-5997-6866
Rodolfo Garcia VillegasDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-0649-6572
Camilla KoolmeisterDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Ilian AtanassovProteomics Core Facility, Max Planck Institute for Biology of Ageing, Cologne, Germany.
Andrea MesarosPhenotyping Core Facility, Max Planck Institute for Biology of Ageing, Cologne, Germany.
Chan Bae ParkAjou University, Suwon, Republic of Korea.
Nils-Göran LarssonDepartment of Mitochondrial Biology, Max Planck Institute for Biology of Ageing, Cologne, Germany nils-goran.larsson@ki.se.ORCID 0000-0001-5100-996X
Karolinska Institutet · SEMax Planck Institute for Biology of Ageing · DEAjou University · KRCologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases · DEWestlake University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial transcription factor A (TFAM) is compacting mitochondrial DNA (dmtDNA) into nucleoids and directly controls mtDNA copy number. Here, we show that the TFAM-to-mtDNA ratio is critical for maintaining normal mtDNA expression in different mouse tissues. Moderately increased TFAM protein levels increase mtDNA copy number but a normal TFAM-to-mtDNA ratio is maintained resulting in unaltered mtDNA expression and normal whole animal metabolism. Mice ubiquitously expressing very high TFAM levels develop pathology leading to deficient oxidative phosphorylation (OXPHOS) and early postnatal lethality. The TFAM-to-mtDNA ratio varies widely between tissues in these mice and is very high in skeletal muscle leading to strong repression of mtDNA expression and OXPHOS deficiency. In the heart, increased mtDNA copy number results in a near normal TFAM-to-mtDNA ratio and maintained OXPHOS capacity. In liver, induction of LONP1 protease and mitochondrial RNA polymerase expression counteracts the silencing effect of high TFAM levels. TFAM thus acts as a general repressor of mtDNA expression and this effect can be counterbalanced by tissue-specific expression of regulatory factors.

Indexed as

AnimalsDNA-Binding ProteinsDNA, MitochondrialDNA ReplicationGene ExpressionGene Expression RegulationHigh Mobility Group ProteinsMaleMiceMice, Inbred C57BLMitochondriaMitochondrial DiseasesMitochondrial ProteinsOxidation-ReductionTranscription FactorsTranscription, GeneticDNA-Binding ProteinsDNA, MitochondrialHigh Mobility Group ProteinsMitochondrial Proteinsmitochondrial transcription factor ATfam protein, mouseTranscription Factors

Identifiers

PMID34462320
PMCPMC8408345
OpenAlexW3197077697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.